These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23381141)

  • 1. Long-term efficacy and safety of botulinum toxin injections in dystonia.
    Ramirez-Castaneda J; Jankovic J
    Toxins (Basel); 2013 Feb; 5(2):249-66. PubMed ID: 23381141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.
    Chinnapongse RB; Lew MF; Ferreira JJ; Gullo KL; Nemeth PR; Zhang Y
    Clin Neuropharmacol; 2012; 35(5):215-23. PubMed ID: 22932474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible adverse effects of intramuscular botulinum toxin injections and their management.
    Bakheit AM
    Curr Drug Saf; 2006 Aug; 1(3):271-9. PubMed ID: 18690938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
    Ramirez-Castaneda J; Jankovic J
    Toxicon; 2014 Nov; 90():344-8. PubMed ID: 25130293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Madarosis and facial alopecia presumed secondary to botulinum a toxin injections.
    Kowing D
    Optom Vis Sci; 2005 Jul; 82(7):579-82. PubMed ID: 16044070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin.
    Childers MK
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):781-92. PubMed ID: 14580037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine use of Xeomin in patients previously treated with Botox: long term results.
    Dressler D
    Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population.
    Kolaski K; Ajizian SJ; Passmore L; Pasutharnchat N; Koman LA; Smith BP
    Am J Phys Med Rehabil; 2008 Jul; 87(7):556-66. PubMed ID: 18574347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
    Colosimo C; Tiple D; Berardelli A
    Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.
    Crowner BE; Torres-Russotto D; Carter AR; Racette BA
    Clin Neuropharmacol; 2010; 33(5):243-7. PubMed ID: 20852412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin and Deep Brain Stimulation in Dystonia.
    de Souza JCC; Falcone ACM; Barbosa RMG; Soares MC; Munhoz R; Farah M; Capato T; Casagrande SCB; Cordellini MF; de Castro Micheli G; Limongi JCP; Barbosa ER; Listik C; Cury RG
    Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.
    Brandenburg JE; Krach LE; Gormley ME
    Am J Phys Med Rehabil; 2013 Oct; 92(10):898-904. PubMed ID: 23636084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hemifacial spasm with botulinum toxin.
    Kobayashi T; Sugasawa K; Ishii K; Takeuchi N
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S193-4. PubMed ID: 10774348
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.